Page 11 - Protein Sciences News Today

Bio-Techne (NASDAQ:TECH – Get Rating) had its target price raised by Robert W. Baird from $99.00 to $100.00 in a report released on Thursday, The Fly reports. Several other research firms also recently weighed in on TECH. Wells Fargo & Company raised Bio-Techne from an underweight rating to an equal weight rating and set a […]

Montanaro Asset Management Ltd raised its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 280.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 387,800 shares of the biotechnology company’s stock after purchasing an additional 285,850 shares during the quarter. Bio-Techne accounts for […]

Bio-Techne (NASDAQ:TECH – Get Rating) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. The company had revenue of $294.15 million for the quarter, compared to analyst estimates of $298.55 million. Bio-Techne had a net margin of 24.15% […]

Bio-Techne (NASDAQ:TECH – Get Rating) posted its earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a return on equity of 15.31% and a net margin of 24.15%. The firm had revenue of $294.15 million during the quarter, compared […]

Bio-Techne (NASDAQ:TECH – Get Rating) issued its earnings results on Wednesday. The biotechnology company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a net margin of 24.15% and a return on equity of 15.31%. The business had revenue of $294.15 million during […]

Bio-Techne (NASDAQ:TECH – Get Rating) had its price target upped by Robert W. Baird from $99.00 to $100.00 in a report issued on Thursday, The Fly reports. TECH has been the topic of several other reports. StockNews.com upgraded Bio-Techne from a hold rating to a buy rating in a research report on Wednesday, April 26th. […]

Bio-Techne Co. (NASDAQ:TECH – Get Rating) declared a quarterly dividend on Wednesday, May 3rd, Zacks reports. Stockholders of record on Monday, May 15th will be paid a dividend of 0.08 per share by the biotechnology company on Friday, May 26th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.37%. […]

Fox Run Management L.L.C. acquired a new stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,658 shares of the biotechnology company’s stock, valued at approximately $386,000. Several other hedge funds and other institutional investors have […]

MINNEAPOLIS, May 3, 2023 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the third quarter ended March 31, 2023. Third Quarter FY2023 Highlights Third quarter... | May 3, 2023

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the BofA...